Search

A recent report from the Department of Obstetrics and Gynecology discusses the risk factors for primary postpartum hemorrhage in vaginal delivery. The study conducted at Paropakar Maternity and Women's Hospital in Nepal found that common risk factors for postpartum hemorrhage include hypertensive disorder in pregnancy, maternal anemia, twin pregnancy, antepartum hemorrhage, fetal macrosomia, and maternal obesity. The study also highlighted that induced and augmented labor, as well as instrumental delivery, can lead to postpartum hemorrhage. The research emphasizes the importance of accurate assessment of blood loss and timely recognition of postpartum hemorrhage to prevent maternal mortality and morbidity. [Extracted from the article]

A new report from the Karolinska Institute explores the relationship between the duration of labor and the risk of postpartum hemorrhage (PPH). The study, which included 77,690 nulliparous women with spontaneous labor onset, found that a prolonged first stage of labor (exceeding 12.1 hours) was associated with a 1.5-fold increased risk of PPH. The researchers also found that a prolonged second stage of labor or cesarean delivery accounted for 18.5% of the increased risk. These findings suggest that including first stage duration in assessments could help identify PPH risk in first-time mothers with spontaneous labor onset. [Extracted from the article]

A recent study conducted in China examined the effects of different exercise interventions on women with gestational diabetes mellitus (GDM). The study found that exercise can reduce insulin resistance and improve outcomes for women with GDM. The three exercise interventions tested were aerobic exercise, resistance training, and a combination of both. The study concluded that the combined aerobic exercise and resistance training intervention was the most effective in reducing blood glucose levels and postpartum bleeding compared to the control group. This information may be useful for pregnant women with GDM who are looking for effective exercise regimens to manage their condition. [Extracted from the article]

A recent study conducted by Leiden University Medical Center in the Netherlands explored the use of prophylactic radiologic interventions to reduce perioperative blood loss during cesarean delivery in women with placenta accreta spectrum disorder. The study involved a systematic review and network meta-analysis of 50 studies, including a total of 5,962 women. The findings suggest that the prophylactic placement of balloon catheters or sheaths before planned cesarean delivery may significantly reduce perioperative blood loss in some cases. However, further research is needed to determine the efficacy and safety of these interventions for different severities of placenta accreta spectrum disorder. [Extracted from the article]

A new report from researchers at Bern University Hospital in Switzerland discusses the use of resuscitative endovascular balloon occlusion of the aorta (REBOA) as a rescue strategy in severe postpartum hemorrhage (PPH). PPH is a leading cause of maternal morbidity and mortality. The case report describes a 29-year-old woman who experienced severe PPH and was successfully treated with REBOA after other treatment options failed. The researchers suggest that REBOA can be an effective strategy for achieving hemodynamic stabilization and preserving reproductive function in cases of severe PPH. This approach is relatively unknown in German-speaking countries. [Extracted from the article]

A recent study conducted by researchers at the University of Technology in Sydney, Australia, examined the management of postpartum hemorrhage (PPH) in basic maternity facilities in South Sudan. The study aimed to evaluate the effects of a capacity-strengthening package on the use of uterotonics for PPH prevention and detection, as well as the use of heat-stable carbetocin (HSC) and tranexamic acid (TXA) for PPH treatment. The intervention package included refresher training, an online provider community, PPH readiness kits, alarm bells, and displayed algorithms. The study found that the intervention package effectively increased the use of HSC and TXA in crisis settings, and it could be scaled up in similar contexts with ongoing supervision. The researchers emphasized the importance of sustaining cold chain investments to ensure the quality of oxytocin, another medication used for PPH treatment. [Extracted from the article]

A recent report from Leiden University Medical Center discusses the use of recombinant activated factor VII (rFVIIa) in the treatment of severe postpartum hemorrhage (PPH). The researchers conducted a systematic literature review and meta-analysis to assess the incidence of thromboembolic events (TEs) in women with PPH treated with rFVIIa compared to those not treated with it. The analysis included 55 publications reporting on 611 women treated with rFVIIa and 32,488 women not treated with it. The estimated proportions of TEs were small and similar between the two groups, indicating a need for further well-designed trials to better understand TE incidence in PPH. [Extracted from the article]

A study conducted by Oregon Health & Science University (OHSU) provides new insights into postpartum hemorrhage, a common complication of the third stage of labor. The study examines various interventions to prevent postpartum hemorrhage and promote maternal and neonatal health. The researchers recommend the use of effective pharmacologic postpartum hemorrhage prophylaxis, delayed cord clamping, early skin-to-skin contact, and controlled cord traction at delivery. They also suggest replacing the term "active management of the third stage of labor" with "third stage care" to emphasize evidence-based interventions that prioritize the safety and well-being of both the woman and neonate. [Extracted from the article]

A recent study conducted at Northwest Women and Children's Hospital in Xi'an, China, examined the use of plasmin-a2-plasmin inhibitor complex (PIC) and thrombin-antithrombin complex (TAT) in predicting the need for massive transfusion (MT) in patients with postpartum hemorrhage (PPH). The study found that elevated levels of TAT and PIC were independent predictors of MT in PPH patients. The combined use of TAT and PIC was more effective in predicting the need for MT than using either marker alone. These findings suggest that TAT and PIC levels could be useful in risk stratification and management of PPH. [Extracted from the article]

A report discusses research on postpartum hemorrhage (PPH), which is defined as excessive blood loss after childbirth. PPH is a major cause of maternal morbidity and mortality in low- and middle-income countries. The study compared the effectiveness of two drugs, carbetocin and oxytocin, in preventing PPH in women undergoing elective cesarean sections. The results showed that carbetocin was more effective in reducing blood loss and maintaining hemoglobin and hematocrit levels compared to oxytocin. The study suggests that carbetocin may be a better option for preventing PPH in these patients. [Extracted from the article]

A study conducted by Massachusetts General Hospital examined the association between the use of selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) during late pregnancy and the risk of postpartum hemorrhage (PPH). The study analyzed data from the National Pregnancy Registry for Psychiatric Medications and found that overall, SSRI/SNRI exposure was associated with a slightly increased risk of PPH. The risk was higher for women who underwent cesarean section delivery compared to vaginal delivery. However, the study was underpowered to draw definitive conclusions, highlighting the need for further research with larger sample sizes. The findings emphasize the importance of increased clinical monitoring for PPH following cesarean section, particularly in women with other known risk factors for PPH who are exposed to SSRIs/SNRIs during late pregnancy. [Extracted from the article]

A recent report from the University Medical Center Utrecht in the Netherlands discusses new research on von Willebrand disease (VWD) and carriers of hemophilia. The study found that the incidence of severe primary postpartum hemorrhage (PPH) in Dutch women with VWD and hemophilia carriers was 8%, compared to 4.5% in the general population. The research also found that the risk of severe primary PPH in women with VWD and hemophilia carriers remained stable and comparable to the increasing prevalence in the general population. Further research is needed to determine the optimal pregnancy management strategy for safe delivery in these individuals. [Extracted from the article]

A recent study conducted by researchers from Nanjing Medical University in China examined the risk factors for postpartum hemorrhage (PPH) in women with severe pre-eclampsia (sPE). The study included 1953 women with sPE who delivered at the Women's Hospital of Nanjing Medical University between April 2015 and April 2023. The results showed that twin pregnancy, placenta accreta spectrum disorders, and placenta previa were independent risk factors for PPH in women with sPE. Spinal anesthesia was found to reduce the risk of PPH in cesarean deliveries, while magnesium sulfate reduced the incidence of PPH in vaginal deliveries. The researchers concluded that magnesium sulfate should be used aggressively in women with sPE, but further investigation is needed to understand its relationship with PPH risk. [Extracted from the article]

A recent study conducted in South Korea investigated the maternal and neonatal outcomes of second deliveries in women who had undergone uterine artery embolization (UAE) during their first delivery. The study found that women who had UAE during their first delivery had higher risks of placental problems, preterm births, and postpartum hemorrhage in their second delivery. Additionally, their second offspring had an increased risk of major congenital malformations and adverse neonatal outcomes. The study suggests that women with a history of UAE require careful prenatal care and monitoring during subsequent deliveries. Further research is needed to understand the mechanisms of complications and improve UAE procedures. [Extracted from the article]

A study conducted at George Washington University examined the use of noninvasive hemoglobin (SpHb) measurement during cesarean deliveries to identify patients at risk for postpartum hemorrhage (PPH). The study found that a decrease in SpHb was associated with an increased risk of PPH, while pre- and postoperative SpHb measurements were positively related to hemoglobin levels. Continuous SpHb measurements during surgery may allow for earlier recognition of PPH and prevent unnecessary blood transfusions. The study suggests that SpHb measurements are reflective of hemoglobin levels and could be a useful tool in PPH management. [Extracted from the article]

A recent study conducted in Pasig City, Philippines, compared the effectiveness of carbetocin and oxytocin in preventing postpartum hemorrhage (PPH). The study found that carbetocin showed statistically significant protection against the need for additional uterotonic administration and the need for blood transfusion. However, there was no statistically significant difference in the reduction of PPH between the two drugs. This research provides valuable insights into the prevention of PPH and may inform medical practices in the future. [Extracted from the article]

A report from Columbia University discusses the impact of postpartum hemorrhage (PPH) on breastfeeding success after vaginal delivery. The study found that women who experienced PPH had fewer breastfeeding sessions on average and required more time at each session. Additionally, neonates of women with PPH had a higher percentage of weight loss in the first few days of life. The researchers suggest that women who experience PPH may require additional support for successful breastfeeding initiation. Further research is needed to understand the mechanism behind this association. [Extracted from the article]

A recent study conducted by the University of Arizona has provided new data on postpartum hemorrhage, a common complication after childbirth. The research found that a genetic variant in the oxytocin receptor gene (OXTR) interacts with epigenetic factors, specifically DNA hydroxymethylation, to affect gene expression in the myometrium, the muscle layer of the uterus. This interaction also has implications for clinical outcomes such as the quantity of oxytocin administration and the odds of experiencing postpartum hemorrhage. The findings offer potential avenues for predicting how women will respond to pharmacological agents in the prevention and treatment of postpartum hemorrhage. [Extracted from the article]

Researchers at China University of Geosciences have conducted a study on postpartum hemorrhage (PPH) in cesarean sections using machine learning (ML) methods. The study cohort consisted of 6,144 subjects, and six different ML models were used to predict the amount of bleeding during cesarean section. The results showed that the random forest model had the highest accuracy for PPH amount prediction. This research provides early warning for clinicians, reduces complications, and improves the safety of cesarean sections. [Extracted from the article]

A recent study conducted at the Fourth Affiliated Hospital in Jiangsu, China, examined the impact of polycystic ovary syndrome (PCOS) on pregnancy outcomes in women with gestational diabetes mellitus (GDM). The study found that women with both PCOS and GDM had higher levels of plasma glucose, increased rates of postpartum hemorrhage, and lower APGAR scores in newborns compared to women with GDM alone. The researchers recommend close monitoring of blood glucose levels and timely intervention measures to optimize outcomes for pregnant women with PCOS and GDM. [Extracted from the article]

A new report from the Albert Einstein College of Medicine discusses the association between resolved placenta previa and postpartum hemorrhage (PPH). The study found that women with a resolved low-lying placenta or placenta previa are still at a significantly increased risk of bleeding-related complications during pregnancy and delivery compared to those who never had a previa. The research suggests that clinicians should consider this association when counseling patients and assessing hemorrhage risk. The study was conducted retrospectively and included 450 women. [Extracted from the article]

A study conducted by researchers at Huazhong University of Science and Technology in Hubei, China, examined the use of Bakri intrauterine balloon tamponade (IUBT) in the treatment of postpartum hemorrhage (PPH) in women with and without placenta accreta spectrum disorder (PAS). The study analyzed the outcomes of 198 women who underwent treatment for PPH using IUBT and found that accurate and timely pre-IUBT intervention and Bakri IUBT placement were crucial for controlling PPH, especially in women with PAS. The study highlights the increasing incidence of PAS and the importance of effective interventions for managing PPH in high-risk maternal populations. [Extracted from the article]

A recent study conducted at the Federal Medical Centre compared the effectiveness and side effects of oral Misoprostol and intramuscular oxytocin in managing the third stage of labor. The study included 260 low-risk women in the second stage of labor with anticipated vaginal delivery. The results showed that oral Misoprostol was superior to oxytocin in reducing blood loss at birth and equally effective in preventing postpartum hemorrhage. However, Misoprostol had more side effects compared to oxytocin. This study provides valuable insights into the management of postpartum hemorrhage. [Extracted from the article]

A recent study conducted in Biella, Italy, examined the use of ultrasound guidance during uterine balloon tamponade (UBT) for the treatment of postpartum hemorrhage (PPH). The study included 370 women who underwent vaginal delivery and required UBT. The researchers found that the use of ultrasound guidance during UBT resulted in a higher success rate, reduced blood loss, and shorter procedure times compared to a non-guided approach. These findings suggest that ultrasound guidance can improve the effectiveness and efficiency of UBT in managing postpartum hemorrhage. [Extracted from the article]

A recent study conducted by Huazhong University of Science and Technology in Hubei, China, explored the effectiveness of Bakri intrauterine balloon tamponade (IUBT) in treating severe postpartum hemorrhage (SPPH). The study found that women with SPPH had a high proportion of placenta accrete, and Bakri IUBT demonstrated a global effectiveness of 84.5% in SPPH treatment. Pre-IUBT intervention was found to be predictive of Bakri's success, and the timely use of IUBT during labor may mitigate the impact of risk factors on postpartum hemorrhage. The study concluded that placenta accrete may be the leading cause of SPPH and that Bakri IUBT is an effective and safe measure for its treatment. [Extracted from the article]

A recent study conducted by researchers at Capital Medical University examined the efficacy and safety of low-dose aspirin for preventing preterm birth in nulliparous women. The study analyzed data from seven randomized controlled trials and found that low-dose aspirin was associated with a significant reduction in the rate of preterm birth at less than 34 weeks of gestation. However, it also found that low-dose aspirin increased the risk of postpartum hemorrhage, placental abruption, and cesarean section in nulliparous women. The study did not find a significant effect of low-dose aspirin on the rates of hypertensive disorders of pregnancy or small for gestational age. [Extracted from the article]

A recent study conducted by investigators at the University of Birmingham in the United Kingdom aimed to determine the most effective route of administration for prophylactic uterotonics in preventing postpartum hemorrhage. The researchers conducted a network meta-analysis of 181 studies involving 122,867 women and found that carbetocin and oxytocin administered intravenously, as well as an intramuscular combination of ergometrine and oxytocin, were the most effective in preventing primary postpartum hemorrhage. These findings suggest that further large-scale studies exploring different routes of administration and considering women's perspectives are needed. The research was supported by the NIHR incentive award and has been peer-reviewed. [Extracted from the article]

A recent report discusses research findings on postpartum hemorrhage in women with pregnancy-induced hypertension (PIH) undergoing cesarean delivery (CD). The study compared the effectiveness of Bakri balloon tamponade (BBT) combined with different suture methods in preventing postpartum hemorrhage. The results showed that both BBT combined with B-lynch uterine compression sutures and BBT combined with modified Hayman suture were effective in controlling bleeding, but the latter method resulted in less blood loss, reduced inflammation, improved coagulation function and ovarian function, and a lower incidence of adverse events. This research provides valuable insights for healthcare professionals managing postpartum hemorrhage in women with PIH. [Extracted from the article]

This article discusses a clinical trial that is currently not recruiting participants. The trial, NCT06285396, focuses on studying the effects of medication used to treat low blood pressure during a Cesarean delivery on the uterine muscle tissue and its ability to contract in patients with Type II and gestational diabetes. The study aims to compare uterine contractility patterns and receptor distribution in diabetic and control pregnant patients using small uterine tissue samples. The trial will investigate the effects of different drugs on myometrial samples and is expected to be completed by July 2024. The responsible party for the study is the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Canada. [Extracted from the article]

A study conducted by Baylor University College of Medicine examined the impact of simulation-based educational intervention on postpartum hemorrhage (PPH)-related maternal morbidity outcomes. The study discovered that while the rate of PPH increased after simulation training, there was a decrease in overall hemorrhage-related morbidity. This decrease persisted even after accounting for other factors. Postpartum hemorrhage remains a significant cause of maternal morbidity and mortality, and incorporating simulation into labor and delivery training can enhance outcomes by focusing on early detection and treatment of PPH. This study emphasizes the potential advantages of simulation-based education in reducing preventable maternal morbidity caused by PPH. [Extracted from the article]

A recent study conducted at Jawaharlal Nehru Medical College in India examined the use of tranexamic acid in reducing blood loss during cesarean deliveries in women at high risk of postpartum hemorrhage. The study found that women who received tranexamic acid had significantly less blood loss compared to those who received a placebo. The research highlights the potential benefits of tranexamic acid in preventing postpartum hemorrhage, a leading cause of maternal morbidity and mortality. This information may be valuable for individuals researching pregnancy complications and women's health. [Extracted from the article]

A recent study conducted at Enugu State University of Science and Technology in Nigeria examined the effectiveness and safety of tranexamic acid in reducing intraoperative blood loss during cesarean delivery in women at high risk of postpartum hemorrhage. The study involved 200 pregnant women and found that the group receiving tranexamic acid had significantly lower blood loss, higher postoperative hemoglobin levels, lower incidence of postpartum hemorrhage, and a lower need for additional uterotonic agents compared to the placebo group. The researchers concluded that the routine use of tranexamic acid during cesarean section in high-risk women may be encouraged. [Extracted from the article]

A study conducted at Suzhou Ninth People's Hospital in Jiangsu, China, aimed to examine the factors influencing postpartum hemorrhage (PPH) in natural delivery for pregnant women aged 35 and above. The study included 351 participants and found that age, pregnancy-induced hypertension, low fibrinogen levels, a long third stage of labor, and a high birth weight for the newborn were significantly related to the incidence of PPH. The researchers developed a risk-prediction model that showed good recognition ability and clinical effectiveness. This study provides valuable insights into PPH risk factors for older pregnant women. [Extracted from the article]

A report from the First Affiliated Hospital of Sun Yat-sen University in Guangzhou, China, examines the impact of China's universal two-child policy on high-risk pregnant women. The study found that the implementation of the policy led to an increase in advanced maternal age and multiparous women. The rate of cesarean section significantly decreased overall, especially for women under 35 years old. However, the risk of postpartum hemorrhage increased in women under 35 years old, highlighting the need for prevention strategies in this population. [Extracted from the article]

A study conducted by Zhejiang University in Hangzhou, China, has developed an artificial neural network prediction model for postpartum hemorrhage (PPH) in women with placenta previa who undergo cesarean section. The model was designed using clinical data from 223 women and achieved superior prediction performance compared to conventional machine learning methods. The study highlights the potential of artificial neural networks in identifying the risk of PPH in women with placenta previa during cesarean section. [Extracted from the article]

A recent study conducted at the University of California San Diego (UCSD) examined the prevalence and risk factors of postpartum hemorrhage (PPH) in metropolitan Mozambique, a region in Sub-Saharan Africa. The study found that PPH is a significant contributor to maternal mortality in the area, with higher rates of PPH and maternal deaths among nonlocal women compared to local women. Risk factors for PPH included prepartum anemia and thrombocytopenia. The researchers concluded that identifying and addressing these risk factors could help develop prevention protocols specific to the region. [Extracted from the article]